China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman
BEIJING, Dec. 14, 2018 /PRNewswire/ — China Biologic Products Holdings, Inc. (NASDAQ: CBPO) (“China Biologic” or the “Company”), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that…